THE EFFICACY AND COST-EFFECTIVENESS OF HYDROXYCHLOROQUINE, SULFASALAZINE, METHOTREXATE TRIPLE THERAPY IN PREVENTING RELAPSE OF RHEUMATOID ARTHRITIS

被引：1
|
作者：
Zhao, J. [1 ]
Zhou, W. [1 ]
Wu, Y. [2 ]
Ji, P. [2 ]
Yan, X. [2 ]
Yang, L. [3 ]
Zhang, Z. [1 ]
机构：
[1] Peking Univ, Rheumatol & Immunol Dept, Hosp 1, Beijing, Peoples R China
[2] Peking Univ Clin Res Inst PUCRI, Beijing, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.1926
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0143
引用
收藏
页码：651 / 651
页数：1
相关论文
共 50 条
  • [41] Combination DMARD therapy with methotrexate (M) sulfasalazine (S) hydroxychloroquine (H) in rheumatoid arthritis (RA): Continued efficacy with minimal toxicity at 5 years.
    O'Dell, J
    Paulsen, G
    Haire, C
    Palmer, W
    Wees, S
    Eckhoff, J
    Klassen, L
    Moore, G
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S132 - S132
  • [42] How different is the status of depression and anxiety in patients with rheumatoid arthritis receiving methotrexate with sulfasalazine or hydroxychloroquine?
    Babaei, Mansour
    Dorparvar, Mehdi
    Ghahari, Behnaz Yousef
    Heidari, Behzad
    Gholinia, Hemmat
    Moudi, Sussan
    [J]. RUSSIAN OPEN MEDICAL JOURNAL, 2023, 12 (03)
  • [43] A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine
    Wojciechowski, Jessica
    Wiese, Michael D.
    Proudman, Susanna M.
    Foster, David J. R.
    Upton, Richard N.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (05) : 777 - 788
  • [44] Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial
    de Jong, Pascal H. P.
    Hazes, Johanna M.
    Buisman, Leander R.
    Barendregt, Pieternella J.
    van Zeben, Derkjen
    van der Lubbe, Peter A.
    Gerards, Andreas H.
    de Jager, Mike H.
    de Sonnaville, Peter B. J.
    Grillet, Bernard A.
    Luime, Jolanda J.
    Weel, Angelique E. A. M.
    [J]. RHEUMATOLOGY, 2016, 55 (12) : 2138 - 2147
  • [45] Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs
    James Dale
    Nicola Alcorn
    Hilary Capell
    Rajan Madhok
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 : 450 - 458
  • [46] Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs
    Dale, James
    Alcorn, Nicola
    Capell, Hilary
    Madhok, Rajan
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (08): : 450 - 458
  • [47] Regimen of rheumatoid arthritis. The triple combination of Methotrexate plus Sulfasalazine plus Hydroxychloroquine is more than just an alternative to Leflunomide.
    Zeidler, Henning
    [J]. AKTUELLE RHEUMATOLOGIE, 2010, 35 (02) : 129 - 131
  • [48] A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis
    Choi, HK
    Seeger, JD
    Kuntz, KM
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (10): : 2316 - 2327
  • [49] THE COST-EFFECTIVENESS OF LIVER-BIOPSY IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH METHOTREXATE
    BERGQUIST, SR
    FELSON, DT
    PRASHKER, MJ
    FREEDBERG, KA
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (03): : 326 - 333
  • [50] Improved tolerance and cost-effectiveness of subcutaneous vs oral methotrexate in rheumatoid arthritis (RA) and juvenile rheumatoid arthritis (JRA).
    Robbins, OB
    Ferriss, JA
    Newman, E
    MaClary, S
    Ayoub, W
    Harrington, T
    Perruquet, J
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S75 - S75
12345